NCT03128489 Evaluation of Immunogenicity and Safety of DTPa-IPV/Hib Conjugate Vaccine (Infanrix™-IPV/Hib) Administered at 6, 10 and 14 Weeks in Healthy Indian Infants Status WITHDRAWN Phase PHASE3
NCT03125616 Babies Born Early Antibody Response to Men B Vaccination: BEAR Men B Status COMPLETED Phase PHASE4
NCT03122223 Evaluating the Safety and Immunogenicity of ALVAC-HIV and MF59®- or AS01B-adjuvanted Bivalent Subtype C gp120 in Healthy, HIV-uninfected Adult Participants Status COMPLETED Phase PHASE1/PHASE2
NCT03119688 To Assess the Mildness of a Cosmetic Cleanser in Healthy Participants Using the Forearm-Controlled Application Technique (FCAT) Status COMPLETED Phase NA
NCT03114969 Comparative Study of Error Rates Between ELLIPTA® Dry Powder Inhaler (DPI) and Other DPIs Status COMPLETED Phase N/A
NCT03110952 TDENV PIV and LAV Dengue Prime-boost Strategy Using AS03B Adjuvant Status WITHDRAWN Phase PHASE1
NCT03105297 To Characterize the Performance of the Nasal Dilator Strip in Lowering Nasal Resistance During Sleep, Promoting Nasal Route Breathing and Reducing the Signs and Symptoms of Sleep Disordered Breathing in a Group of Chronic Nocturnal Nasal Congestion Sufferers Who Report Trouble With Their Sleep. Status COMPLETED Phase PHASE2
NCT03103906 Evaluation of the Cosmetic Benefit of a Skin Cream in Healthy Females With Mild to Advanced Photo-damaged Facial Skin Who Have Undergone a Glycolic Acid Facial Peel Procedure Status COMPLETED Phase NA
NCT03095638 Bioavailability Study of 10 Milligram (mg) and 5 mg Tablets Versus Conventional Tablets of Dolutegravir Status COMPLETED Phase PHASE1
NCT03093181 A Study to Evaluate of Cosmetic Benefit of a Moisturising Cream in People With Blemish Prone Skin Status COMPLETED Phase NA
NCT03089879 A Study to Evaluate Safety and Immunogenicity of 1 Booster Dose of 1790GAHB Vaccine in Healthy Adults Primed With 3 Doses of 1790GAHB Vaccine in Study H03_01TP Compared to 1 Vaccination of 1790GAHB in Either Subjects Who Received Placebo in the Same Study or naïve Subjects Not Part of H03_01TP Study Status COMPLETED Phase PHASE1
NCT03083509 A Physiological Profile of Recovery From Resistance, Endurance, and Mixed Exercise Types Status COMPLETED Phase NA
NCT03078556 Bioequivalence Study of Fixed Dose Versus Single Entities of Dolutegravir and Lamivudine Status COMPLETED Phase PHASE1
NCT03076164 A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib Status COMPLETED Phase PHASE1/PHASE2
NCT03075410 First Time in Human (FTIH) Safety and Pharmacokinetics (PK) Study of GSK3036656 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT03072719 The Efficacy of a Dentifrice in Providing Relief From Immediate and Short Term Relief From Dentinal Hypersensitivity Status COMPLETED Phase PHASE3
NCT03069989 Single Doses of GSK3008348 in Idiopathic Pulmonary Fibrosis (IPF) Participants Using Positron Emission Tomography (PET) Imaging Status TERMINATED Phase PHASE1